TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT06486454: Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

Sponsor: HistoSonics, Inc. · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 5000 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$14,784,000

Rescue Site Savings

+$9,748,200

Unlock Full NCT06486454 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06486454 Rescue Dossier →